Natalia Podlutskaya

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

Patricia Spilman, Natalia Podlutskaya, Matthew J. Hart et al. · PLoS ONE · 2010 · 993 citations · Full text

Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice

Jonathan J. Halloran, Stacy A. Hussong, Raquel R Burbank et al. · Neuroscience · 2012 · 213 citations · Full text

Lifespan Extension, Mammalian Target, Neuropsychology +12

Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease

Juan Beauquis, Patricio Pavía, Carlos Pomilio et al. · Experimental Neurology · 2012 · 174 citations

Alzheimer's Disease, Dementia, Degenerative Pathology +9

The long lifespan of two bat species is correlated with resistance to protein oxidation and enhanced protein homeostasis

Adam B. Salmon, Shanique Leonard, V. Pragathi Masamsetti et al. · The FASEB Journal · 2009 · 115 citations · Full text

Lipid Peroxidation, Biogerontology, Redox Biology +19

Over‐expression of heat shock factor 1 phenocopies the effect of chronic inhibition of <scp>TOR</scp> by rapamycin and is sufficient to ameliorate Alzheimer's‐like deficits in mice modeling the disease

Anson Pierce, Natalia Podlutskaya, Jonathan J. Halloran et al. · Journal of Neurochemistry · 2012 · 81 citations · Full text

Cell Death, Social Sciences, Neuroinflammation +26